Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Biostatistics: Overview01:20

Biostatistics: Overview

Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-to-progression ratio as a potential study endpoint in early-phase oncology trials: pooled analysis of phase II trials from the Australian MoST program.

Future oncology (London, England)·2026
Same author

A Review of Virtual Twins in Physiologically-Based Pharmacokinetic Modeling and Simulation.

Clinical pharmacology and therapeutics·2026
Same author

Effects of Gastric Acid Suppression, Cytochrome P4503A Inhibition and Induction, and Food on the Pharmacokinetics of Tinlarebant in Healthy Adults.

Clinical pharmacology in drug development·2026
Same author

Reply to "Minor Contribution of UGT1A1 Inhibition to Atazanavir-Related Bilirubin Elevation Supported by Conservative PBPK Modeling and Clinical Data".

Clinical pharmacology and therapeutics·2025
Same author

Oral anticoagulation for adults with atrial fibrillation or venous thromboembolism.

Australian prescriber·2025
Same author

Using pharmacogenomics to personalise drug therapy: which drugs, when and how.

Australian prescriber·2025

Related Experiment Video

Updated: Jun 2, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

BICEPP: an example-based statistical text mining method for predicting the binary characteristics of drugs.

Frank P Y Lin1, Stephen Anthony, Thomas M Polasek

  • 1Centre for Health Informatics, The University of New South Wales, Sydney, Australia. f.lin@unsw.edu.au

BMC Bioinformatics
|April 23, 2011
PubMed
Summary

A new text-mining tool, BICEPP, automates drug characteristic identification, aiding experts in screening large drug databases for clinical properties and potential adverse events.

More Related Videos

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Related Experiment Videos

Last Updated: Jun 2, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

Area of Science:

  • Biomedical Informatics
  • Natural Language Processing
  • Pharmacology

Background:

  • Identifying drug characteristics is crucial but resource-intensive.
  • Expert knowledge is traditionally required for drug screening.
  • A novel statistical text-mining approach, BICEPP, is introduced to assist experts.

Purpose of the Study:

  • To develop and validate a text-mining tool for automated drug characteristic identification.
  • To assess BICEPP's performance in classifying drugs based on clinical properties.
  • To facilitate efficient screening of large drug databases.

Main Methods:

  • BICEPP retrieves MEDLINE abstracts containing drug names.
  • It selects predictive tokens to represent drug characteristics.
  • Machine learning classifies drugs using a document frequency-based measure.

Main Results:

  • BICEPP achieved high accuracy in classifying major (100%) and minor (80%) therapeutic drug classes.
  • Performance metrics (AUC > 0.80) were obtained for adverse event classification (73%) and CYP enzyme interactions (80%).
  • Accurate classification was also observed for narrow therapeutic index drugs (79%).

Conclusions:

  • BICEPP demonstrates robust classification power for diverse drug properties.
  • The tool can automate the identification of clinically significant drug characteristics.
  • BICEPP is suitable for pharmacovigilance to rapidly screen drug databases.